Status: Recruiting
Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults
Phase III clinical trial to evaluate the efficacy and safety of a fixed-dose combination of 1000 mg dipyrone monohydrate + 60 mg caffeine + 4 mg chlorpheniramine maleate in improving symptoms of the common cold and flu in adults.
Participants needed: 620
Trial details
Phase: Phase 3Age: 18-60Biological sex: AllType: InterventionalSponsor: Brainfarma Industria Química e Farmacêutica S/AUpdated: Jun 16, 2026Locations: 15
Eligibility criteria
Participants of both sexes, aged between 18 and 60 years. [+4]
Participants with COVID-19, diagnosed by rapid antigen test and/or RT-PCR for SA... [+15]